Holy Stone Healthcare Co., Ltd., together with representatives of MDT Int’l S.A., attended 2017 BIO International Convention in San Diego, USA. on June 19-22.
During the exhibition, our two major developing products, IBD98-M & CA102N, were introduced. IBD98-M is a combination drug to treat mild to moderate Ulcerative Colitis, and CA102N is an anti-cancer drug-conjugate for targeted delivery to malignant cells. MDT Int’l also exhibited its medical devices products.